ISTH 2022 Congress
Acquired Bleeding Disorders » Management/Treatments of Acquired Bleeding
Theme Navigation
- ISTH 2022 Congress
- Acquired Bleeding Disorders
- Management/Treatments of Acquired Bleeding
- Acquired Bleeding Disorders
-
Abstract Number: PB0988
A TEG-guided treatment algorithm for major surgical bleeding
-
Abstract Number: PB0989
Acquired Factor V Inhibitor In a Patient With Metastatic Cancer
-
Abstract Number: PB0990
Acquired FXI deficiency (aFXIdef) in a HIV + patient with SLE. Alternative evolution to lupus Anticoagulant (LA) during immunosuppressive therapy.
-
Abstract Number: PB0005
Acquired haemophilia presenting in a 14-year-old girl
-
Abstract Number: VPB0003
Acquired von Willebrand syndrome in patients with monoclonal gammopathy: a single centre experience.
-
Abstract Number: VPB0997
Analytical performance of different laboratory methods for measuring susoctog-alpha
-
Abstract Number: PB0991
Assessment of Interference by Emicizumab in the Measurement of Susoctocog Alfa Factor VIII Activity Using a Chromogenic Assay
-
Abstract Number: PB0985
Clinical experience in factor Xa inhibitors´ reversal with prothrombin complex concentrate in emergency settings
-
Abstract Number: PB0006
Delayed Diagnosis of Acquired Hemophilia A Results in Worse Clinical Outcome
-
Abstract Number: PB0984
Direct comparison of Andexanet alfa and prothrombin complex concentrates in the reversal of direct factor Xa inhibitors – An in vitro study
-
Abstract Number: PB0986
Efficacy and safety of prothrombin complex concentrate for major bleeding in patients treated with direct Factor-Xa inhibitors
-
Abstract Number: PB0002
Emicizumab for the treatment of acquired hemophilia A: an update of the Vienna experience
-
Abstract Number: VPB0004
Evaluation of the utility of BAT (ISTH-SSC bleeding assessment tool) questionnaire in the diagnostic of acquired von Willebrand syndrome
-
Abstract Number: OC 24.4
Factor XIII levels correlate with fibrinogen concentrations in patients with venous malformations and chronic disseminated intravascular coagulopathy
-
Abstract Number: VPB0996
FiiRST-2; a prospective, randomized study of clotting factor concentrates versus standard massive hemorrhage protocol in severely bleeding trauma patients
-
Abstract Number: PB0987
Impact of amotosalen/UVA process for pathogen reduction in platelet concentrates on transfusion efficiency in cardiac surgery
-
Abstract Number: OC 11.3
Improved Survival in Severely Bleeding Trauma Patients Treated with Low-titer Group O Whole Blood Compared to Component Therapy
-
Abstract Number: PB0980
Intravenous Ferric Gluconate Use in Anemic Heart Failure Patients at a Large Academic Medical Center
-
Abstract Number: PB0001
Management of acquired haemophilia A in a Portuguese Center: 16 years and 16 cases